GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin :

Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.

Related Keywords

Lebanon , South Korea , New York , United States , Rachel Pessah , Dulaglutide Trulicity , Epic Research , University Of North Carolina At Chapel Hill , Novo Nordisk , While The Epic Research , North Carolina , Chapel Hill , Medscape Medical News , Rachel Pessah Pollack , Ambulatory Care , Lake Success , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Thyroid Disorder , Malignant Head And Neck Neoplasm , Thyroid Cancer , Thyroid Carcinoma , Ancer Of The Thyroid , Medullary Thyroid Carcinoma , Edullary Carcinoma Of The Thyroid , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Thyroid , Cancer , Alignant Neoplasia , Arcinoma , Receptors , Healthcare Technology , Ealth Care T ,